[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Hollowell Jr et al., 1968 - Google Patents

Homocystinuria as affected by pyridoxine, folic acid, and vitamin B12

Hollowell Jr et al., 1968

Document ID
782948722464287723
Author
Hollowell Jr J
Coryell M
Hall W
Findley J
Thevaos T
Publication year
Publication venue
Proceedings of the Society for Experimental Biology and Medicine

External Links

Snippet

Summary and Conclusions Administration of pyridoxine to the four children with homocystinuria who had been on a diet low in pyridoxine resulted in ablation of a general but slight aminoaciduria and a striking reduction in homocystine excretion. Further studies …
Continue reading at journals.sagepub.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl group being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Similar Documents

Publication Publication Date Title
Krause et al. Biochemical and neuropsychological effects of elevated plasma phenylalanine in patients with treated phenylketonuria. A model for the study of phenylalanine and brain function in man.
Roe et al. Metabolic response to carnitine in methylmalonic aciduria. An effective strategy for elimination of propionyl groups.
Mertz et al. Relation of glucose tolerance factor to impaired intravenous glucose tolerance of rats on stock diets
Morris et al. Ammonia intoxication in the near-adult cat as a result of a dietary deficiency of arginine
Finkelstein et al. Regulation of the betaine content of rat liver
Dillon et al. Mental retardation, megaloblastic anaemia, methylmalonic aciduria and abnormal homocysteine metabolism due to an error in vitamin B12 metabolism
Holt et al. Whole body protein turnover in malnourished cystic fibrosis patients and its relationship to pulmonary disease
Gersovitz et al. Dynamic aspects of whole body glycine metabolism: influence of protein intake in young adult and elderly males
Hollowell Jr et al. Homocystinuria as affected by pyridoxine, folic acid, and vitamin B12
Furst et al. Salicylate metabolism in twins: Evidence suggesting a genetic influence and induction of salicylurate formation
Brandt et al. Propionicacidemia (ketotic hyperglycinemia): dietary treatment resulting in normal growth and development
Daniel et al. Adaptation of the weanling rat to diets containing excess methionine
Schubiger et al. N-acetylglutamate synthetase deficiency: diagnosis, management and follow-up of a rare disorder of ammonia detoxication
Carson et al. Treatment of homocystinuria with pyridoxine. A preliminary study.
Richards et al. Synthesis of phenylalanine and valine by healthy and uraemic men
Cederbaum et al. Treatment of hyperargininaemia due to arginase deficiency with a chemically defined diet
Wilcken et al. Homocystinuria: reduced folate levels during pyridoxine treatment
Cohen et al. High pyridoxine diet in the rat: possible implications for megavitamin therapy
Yudkoff et al. Glycine therapy in isovaleric acidemia
McReynolds et al. Treatment of complete ornithine transcarbamylase deficiency with nitrogen-free analogues of essential amino acids
Li et al. Plasma PLP as indicator of nutrition status: relationship to tissue vitamin B-6 content and hepatic metabolism
Young et al. Whole body protein and amino acid metabolism: relation to protein quality evaluation in human nutrition
Yoshida et al. Homocystinuria of vitamin B6 dependent type
Walser Keto acid therapy in chronic renal failure
Plecko et al. Partial N-acetylglutamate synthetase deficiency in a 13-year-old girl: diagnosis and response to treatment with N-carbamylglutamate